According to a new report published by UnivDatos Markets Insights, the Glioblastoma Multiforme Treatment (GBM) market was valued at USD 2 billion in 2021 & is expected to grow at a CAGR of 8% from 2022-2030. The analysis has been segmented into Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, and Immunotherapy); End-Use (Hospitals,...